|
1
|
Wang Y, Liu H, Zhou Q and Li X: Analysis
of point mutation in site 1896 of HBV precore and its detection in
the tissues and serum of HCC patients. World J Gastroenterol.
6:395–397. 2000.PubMed/NCBI
|
|
2
|
Zhuang L, You J, Tang BZ, et al:
Preliminary results of Thymosin-a1 versus interferon-treatment in
patients with HBeA g negative and serum HBV DNA positive chronic
hepatitis B. World J Gastroenterol. 7:407–410. 2001.PubMed/NCBI
|
|
3
|
Henkler F, Hoare J, Waseem N, et al:
Intracellular localization of the hepatitis B virus HBx protein. J
Gen Virol. 82:871–882. 2001.PubMed/NCBI
|
|
4
|
Hoare J, Henkler F, Dowling JJ, et al:
Subcellular localization of the X protein of HBV infected
hepatocytes. J Med Virol. 64:419–246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang H, Delgermaa L, Huang F, et al: The
transcriptional transactivation function of HBx protein is
important for its augmentation role in hepatitis B virus
replication. J Virol. 79:5548–5556. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang JL, Zhao WG, Wu KL, et al: Human
hepatitis B virus X protein promotes cell proliferation and
inhibits cell apoptosis through interacting with a serine protease
Hepsin. Arch Virol. 150:721–741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan DW and Ngi O: Knock-down of hepatitis
B virus X protein reduces the tumorigenicity of hepatocellular
carcinoma cells. J Pathol. 208:372–380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SG, Chung C, Kang H, Kim JY and Jung
G: Up-regulation of cyclin D1 by HBx is mediated by NF-κB2/BCL3
complex through κB site of cyclin D1 promoter. J Biol Chem.
281:31770–31777. 2006.PubMed/NCBI
|
|
9
|
Chen YB, Yan ML, Gong JP, et al:
Establishment of hepatocellular carcinoma multidrug resistant
monoclone cell line HepG2/mdr1. Chin Med J. 120:703–707.
2007.PubMed/NCBI
|
|
10
|
Li H, Cao HF, Wan J, Li Y, Zhu ML and Zhao
P: Growth inhibitory effect of wild-type Kras2 gene on a colonic
adenocarcinoma cell line. World J Gastroenterol. 13:934–938. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sambrook J and Russell DW: Molecular
Cloning: A Laboratory Manual. 3rd edition. Huang P: Science Press;
Beijing: 2002
|
|
12
|
Li K, Wang L, Cheng J, et al: Interaction
between hepatitis C virus core protein and translin protein - a
possible molecular mechanism for hepatocellular carcinoma and
lymphoma caused by hepatitis C virus. World J Gastroenterol.
9:300–303. 2003.
|
|
13
|
Lu YY, Wang L, Liu Y, et al: Interaction
between hepatitis b virus e antigen and the metal sulfur protein.
Jie Fang Jun Yi Xue Za Zhi. 28:451–453. 2003.(In Chinese).
|
|
14
|
Cheng EH, Sheiko TV, Fisher JK, Craigen WJ
and Korsmeyer SJ: VDAC2 inhibits BAK activation and mitochondrial
apoptosis. Science. 301:513–517. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karolchik D, Baertsch R, Diekhans M, et
al; University of California Santa Cruz. The UCSC Genome Browser
Database. Nucleic Acids Res. 31:51–54. 2003. View Article : Google Scholar
|
|
16
|
Rajasekaran S, Thapar V, Dave H and Huang
CH: Randomized and parallel algorithms for distance matrix
calculations in multiple sequence alignment. J Clin Monit Comput.
19:351–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stocker RJ: The asialoglycoprotein
receptors: relationships between structure, function and
expression. Physiol Rev. 75:591–609. 1995.PubMed/NCBI
|
|
18
|
Hajoui O, Martin S and Alvarez F: Study of
antigenic sites on the asialoglycoprotein receptor recognized by
autoantibodies. Clin Exp Immunol. 113:339–345. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spring P, Nakashima T, Frederick M,
Henderson Y and Clayman G: Identification and cDNA cloning of
headpin, a novel differentially expressed serpin that maps to
chromosome 18q. Biochem Biophys Res Commun. 264:299–304. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Montrminy MR and Bilezikjan LM: Binding of
a nuclear protein to the cyclic-AMP response element of the
somatostatin gene. Nature. 328:175–178. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lundblad M, Andersson M, Winkler C, Kirik
D, Wierup N and Cenci MA: Pharmacological validation of behavioural
measures of akinesia and dyskinesia in a rat model of Parkinson’s
disease. Eur J Neurosci. 15:120–132. 2002.PubMed/NCBI
|
|
22
|
Isoda K, Kamezawa Y, Ayaori M, Kusuhara M,
Tada N and Ohsuzu F: Osteopontin transgenic mice fed a
high-cholesterol diet develop early fatty-streak lesions.
Circulation. 107:679–681. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abba MC, Laguens RM, Dulout FN and Golijow
CD: The c-myc activation in cervical carcinomas and HPV 16
infections. Mutat Res. 557:151–158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tseng WF, Huang SS and Huang JS:
LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO
cells. FEBS Lett. 562:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ren F, Jin HY, Guo XH, et al: Erokaryotic
expression and clinical application of X gene of hepatitis B virus.
Wei Chang Bing Xue He Gan Bing Xue Za Zhi. 15:239–241. 2006.(In
Chinese).
|
